Baculoviral transduction facilitates TALEN-mediated targeted transgene integration and Cre/LoxP cassette exchange in human-induced pluripotent stem cells
The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
Abstract
Safety and reliability of transgene integration in human genome continue to pose challenges for stem cell-based gene therapy. Here, we report a baculovirus-transcription activator-like effector nuclease system for AAVS1 locus-directed homologous recombination in human induced pluripotent stem cells (iPSCs). This viral system, when optimized in human U87 cells, provided a targeted integration efficiency of 95.21% in incorporating a Neo-eGFP cassette and was able to mediate integration of DNA insert up to 13.5 kb. In iPSCs, targeted integration with persistent transgene expression was achieved without compromising genomic stability. The modified iPSCs continued to express stem cell pluripotency markers and maintained the ability to differentiate into three germ lineages in derived embryoid bodies. Using a baculovirus-Cre/LoxP system in the iPSCs, the Neo-eGFP cassette at the AAVS1 locus could be replaced by a Hygro-mCherry cassette, demonstrating the feasibility of cassette exchange. Moreover, as assessed by measuring γ-H2AX expression levels, genome toxicity associated with chromosomal double-strand breaks was not detectable after transduction with moderate doses of baculoviral vectors expressing transcription activator-like effector nucleases. Given high targeted integration efficiency, flexibility in transgene exchange and low genome toxicity, our baculoviral transduction-based approach offers great potential and attractive option for precise genetic manipulation in human pluripotent stem cells.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures





Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Unlike ZFNs, design and engineering of TALENs is much simpler and can be done in a shorter time (Cermak et al., 2011; Reyon et al., 2012). TALENs are also not as limited as ZFNs in target site selection due to the 1:1 TALE–DNA binding (Zhu et al., 2013).”
From Delivering CRISPR: a review of the challenges and approaches (2018) · cites this paper as Zhu et al., 2013
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
LMO2 -Associated Clonal T Cell Proliferation in Two Patients after Gene Therapy for SCID-X1
Hacein-Bey-Abina, S., Von Kalle, C., Schmidt, M., McCormack, M. P., Wulffraat, N., Leboulch, P., Lim, A., Osborne, C. S., Pawliuk, R., Morillon, E., et al. (2003) · Science · doi:10.1126/science.1088547 · Cited by 3,587
Megabase Chromatin Domains Involved in DNA Double-Strand Breaks in Vivo
Rogakou, E. P., Boon, C., Redon, C., & Bonner, W. M. (1999) · The Journal of Cell Biology · doi:10.1083/jcb.146.5.905 · Cited by 2,422
Genome editing with engineered zinc finger nucleases
Urnov, F. D., Rebar, E. J., Holmes, M. C., Zhang, H. S., & Gregory, P. D. (2010) · Nature Reviews Genetics · doi:10.1038/nrg2842 · Cited by 2,285
A TALE nuclease architecture for efficient genome editing
Miller, J. C., Tan, S., Qiao, G., Barlow, K. A., Wang, J., Xia, D. F., Meng, X., Paschon, D. E., Leung, E., Hinkley, S. J., et al. (2011) · Nature Biotechnology · doi:10.1038/nbt.1755 · Cited by 2,098
HIV-1 Integration in the Human Genome Favors Active Genes and Local Hotspots
Schröder, A. R. W., Shinn, P., Chen, H., Berry, C., Ecker, J. R., & Bushman, F. (2002) · Cell · doi:10.1016/s0092-8674(02)00864-4 · Cited by 1,832
TALENs: A widely applicable technology for targeted genome editing
Joung, J. K., & Sander, J. D. (2013) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3486 · Cited by 1,650
TAL effectors: customizable proteins for DNA targeting
Bogdanove, A. J., & Voytas, D. F. (2011) · Science · doi:10.1126/science.1204094 · Cited by 984
A novel TALE nuclease scaffold enables high genome editing activity in combination with low toxicity
Mussolino, C., Morbitzer, R., Lütge, F., Dannemann, N., Lahaye, T., & Cathomen, T. (2011) · Nucleic Acids Research · doi:10.1093/nar/gkr597 · Cited by 714
Structure-based redesign of the dimerization interface reduces the toxicity of zinc-finger nucleases
Szczepek, M., Brondani, V., Büchel, J., Serrano, L., Segal, D. J., & Cathomen, T. (2007) · Nature Biotechnology · doi:10.1038/nbt1317 · Cited by 501 · cited 1×
“At high ZFN concentrations, activation of the nuclease that cleaves at non-intentional sites may occur due to ZFN dimerization in the absence of DNA binding at related sequences (41).”
BackgroundTargeted genome editing in human cells with zinc finger nucleases constructed via modular assembly
Kim, H. J., Lee, H. J., Kim, H., Cho, S. W., & Kim, J.-S. (2009) · Genome Research · doi:10.1101/gr.089417.108 · Cited by 466 · cited 1×
“Thus, the T7EI assay has been used as a standard assay in the field to detect whether ZFNs or TALENs can cut endogenous target sequences in cells (28,29).”
Method
Research works printed but not linked: 30
- Turan S Bode J Site-specific recombinases: from tag-and-target- to tag-and-exchange-based genomic modifications FASEB J. 2011 25 4088– 4107 21891781 · DOI · Paper page
- Deng D Yan CY Pan XJ Mahfouz M Wang JW Zhu JK Shi YG Yan NE Structural basis for sequence-specific recognition of DNA by TAL effectors Science 2012 335 720– 723 22223738 PMC3586824 · DOI · Paper page
- Mak ANS Bradley P Cernadas RA Bogdanove AJ Stoddard BL The Crystal Structure of TAL Effector PthXo1 Bound to Its DNA Target Science 2012 335 716– 719 22223736 PMC3427646 · DOI · Paper page
- Boch J Scholze H Schornack S Landgraf A Hahn S Kay S Lahaye T Nickstadt A Bonas U Breaking the Code of DNA Binding Specificity of TAL-Type III Effectors Science 2009 326 1509– 1512 19933107 · DOI · Paper page
- Hockemeyer D Wang HY Kiani S Lai CS Gao Q Cassady JP Cost GJ Zhang L Santiago Y Miller JC Genetic engineering of human pluripotent cells using TALE nucleases Nat. Biotechnol. 2011 29 731– 734 21738127 PMC3152587 · DOI · Paper page
- Sanjana NE Cong L Zhou Y Cunniff MM Feng GP Zhang F A transcription activator-like effector toolbox for genome engineering Nat. Protoc. 2012 7 171– 192 22222791 PMC3684555 · DOI · Paper page
- Reyon D Tsai SQ Khayter C Foden JA Sander JD Joung JK FLASH assembly of TALENs for high-throughput genome editing Nat. Biotechnol. 2012 30 460– 465 22484455 PMC3558947 · DOI · Paper page
- Cermak T Doyle EL Christian M Wang L Zhang Y Schmidt C Baller JA Somia NV Bogdanove AJ Voytas DF Efficient design and assembly of custom TALEN and other TAL effector-based constructs for DNA targeting Nucleic Acids Res. 2011 39 7879– 7879 PMC3130291 21493687 · DOI · Paper page
- Sun N Liang J Abil Z Zhao HM Optimized TAL effector nucleases (TALENs) for use in treatment of sickle cell disease Mol. Biosyst. 2012 8 1255– 1263 22301904 · DOI · Paper page
- Bedell VM Wang Y Campbell JM Poshusta TL Starker CG Krug RG Tan WF Penheiter SG Ma AC Leung AYH In vivo genome editing using a high-efficiency TALEN system Nature 2012 491 114– 133 23000899 PMC3491146 · DOI · Paper page
- Carlson DF Tan WF Lillico SG Stverakova D Proudfoot C Christian M Voytas DF Long CR Whitelaw CBA Fahrenkrug SC Efficient TALEN-mediated gene knockout in livestock Proc. Natl Acad. Sci. USA 2012 109 17382– 17387 23027955 PMC3491456 · DOI · Paper page
- Zeng JM Du J Zhao Y Palanisamy N Wang S Baculoviral vector-mediated transient and stable transgene expression in human embryonic stem cells Stem Cells 2007 25 1055– 1061 17420229 · DOI · Paper page
- Chen GY Hwang SM Su HJ Kuo CY Luo WY Lo KW Huang CC Chen CL Yu SH Hu YC Defective antiviral responses of induced pluripotent stem cells to baculoviral vector transduction J. Virol. 2012 86 8041– 8049 22623765 PMC3421682 · DOI
- Chen GY Pang DWP Hwang SM Tuan HY Hu YC A graphene-based platform for induced pluripotent stem cells culture and differentiation Biomaterials 2012 33 418– 427 22014460 · DOI · Paper page
- Yang J Lam DH Goh SS Lee EX Zhao Y Tay FC Chen C Du SH Balasundaram G Shahbazi M Tumor tropism of intravenously injected human-induced pluripotent stem cell-derived neural stem cells and their gene therapy application in a metastatic breast cancer model Stem Cells 2012 30 1021– 1029 22311724 · DOI
- Kost TA Condreay JP Recombinant baculoviruses as mammalian cell gene-delivery vectors Trends Biotechnol. 2002 20 173– 180 11906750 · DOI · Paper page
- Pieroni L La Monica N Towards the use of baculovirus as a gene therapy vector Curr. Opin. Mol. Ther. 2001 3 464 467 11699890
- DeKelver RC Choi VM Moehle EA Paschon DE Hockemeyer D Meijsing SH Sancak Y Cui XX Steine ELJ Miller JC Functional genomics, proteomics, and regulatory DNA analysis in isogenic settings using zinc finger nuclease-driven transgenesis into a safe harbor locus in the human genome Genome Res. 2010 20 1133– 1142 20508142 PMC2909576 · DOI · Paper page
- Ogata T Kozuka T Kanda T Identification of an insulator in AAVS1, a preferred region for integration of adeno-associated virus DNA J. Virol. 2003 77 9000– 9007 12885916 PMC167236 · DOI · Paper page
- Smith JR Maguire S Davis LA Alexander M Yang FT Chandran S Ffrench-Constant C Pedersen RA Robust, persistent transgene expression in human embryonic stem cells is achieved with AAVS1-targeted integration Stem Cells 2008 26 496– 504 18024421 · DOI · Paper page
- Ramachandra CJA Shahbazi M Kwang TWX Choudhury Y Bak XY Yang J Wang S Efficient recombinase-mediated cassette exchange at the AAVS1 locus in human embryonic stem cells using baculoviral vectors Nucleic Acids Res. 2011 39 e107 21685448 PMC3167641 · DOI · Paper page
- Reyon D Tsai SQ Khayter C Foden JA Sander JD Joung JK FLASH assembly of TALENs for high-throughput genome editing Nat. Biotechnol. 2012 30 460– 465 22484455 PMC3558947 · DOI · Paper page
- Rogakou EP Pilch DR Orr AH Ivanova VS Bonner WM DNA double-stranded breaks induce histone H2AX phosphorylation on serine 139 J. Biol. Chem. 1998 273 5858– 5868 9488723 · DOI · Paper page
- Yao S Sukonnik T Kean T Bharadwaj RR Pasceri P Ellis J Retrovirus silencing, variegation, extinction, and memory are controlled by a dynamic interplay of multiple epigenetic modifications Mol. Ther. 2004 10 27– 36 15233939 · DOI · Paper page
- Xia X Zhang Y Zieth CR Zhang SC Transgenes delivered by lentiviral vector are suppressed in human embryonic stem cells in a promoter-dependent manner Stem Cells Dev. 2007 16 167– 176 17348812 PMC2801347 · DOI · Paper page
- Moehle EA Rock JM Lee YL Jouvenot Y DeKelver RC Gregory PD Urnov FD Holmes MC Targeted gene addition into a specified location in the human genome using designed zinc finger nucleases Proc. Natl Acad. Sci. USA 2007 104 6090– 6090 PMC1802009 17360608 · DOI · Paper page
- Ellis J Silencing and variegation of gammaretrovirus and lentivirus vectors Hum. Gene. Ther. 2005 16 1241– 1246 16259557 · DOI · Paper page
- Handel EM Gellhaus K Khan K Bednarski C Cornu TI Muller-Lerch F Kotin RM Heilbronn R Cathomen T Versatile and efficient genome editing in human cells by combining zinc-finger nucleases with adeno-associated viral vectors Hum. Gene. Ther. 2012 23 321– 329 21980922 PMC3300077 · DOI · Paper page
- van Oers MM Vlak JM Baculovirus genomics Curr. Drug. Targets 2007 8 1051– 1068 17979665 · doi:10.2174/138945007782151333
- Du ZW Hu BY Ayala M Sauer B Zhang SC Cre recombination-mediated cassette exchange for building versatile transgenic human embryonic stem cells lines Stem Cells 2009 27 1032– 1041 19415769 PMC2801346 · DOI
Cited by
Delivering CRISPR: a review of the challenges and approaches
Lino, C. A., Harper, J. C., Carney, J. P., & Timlin, J. A. (2018) · Drug Delivery · doi:10.1080/10717544.2018.1474964 · Cited by 1,185
“TALENs are also not as limited as ZFNs in target site selection due to the 1:1 TALE–DNA binding (Zhu et al., 2013).”
BackgroundTargeted drug delivery strategies for precision medicines
Manzari, M. T., Shamay, Y., Kiguchi, H., Rosen, N., Scaltriti, M., & Heller, D. A. (2021) · Nature Reviews Materials · doi:10.1038/s41578-020-00269-6 · Cited by 1,183
Lau, C.-H., & Suh, Y. (2017) · F1000Research · doi:10.12688/f1000research.11243.1 · Cited by 161
Self-citationCurrent and future delivery systems for engineered nucleases: ZFN, TALEN and RGEN
Ain, Q. U., Chung, J. Y., & Kim, Y.-H. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.12.036 · Cited by 130
Genome Editing in Human Pluripotent Stem Cells: Approaches, Pitfalls, and Solutions
Hendriks, W. T., Warren, C. R., & Cowan, C. A. (2016) · Cell Stem Cell · doi:10.1016/j.stem.2015.12.002 · Cited by 110
“Viral vector-mediated delivery of CRISPR/Cas9 gene-editing constructs into hPSCs has been successful, especially non-integrating viral vectors such as adenovirus and baculovirus (Zhu et al., 2013).”
Background
Metadata
- Authors
- Zhu, H., Lau, C.-H., Goh, S.-L., Liang, Q., Chen, C., Du, S., Phang, R.-Z., Tay, F. C., Tan, W.-K., Li, Z., Tay, J. C.-K., Fan, W., & Wang, S.
- Affiliations
- Department of Biological Sciences, National University of Singapore, 117543 Singapore, 2Department of Surgery, Program of Innovative Cancer Therapeutics, First Affiliated Hospital of Zhejiang University College of Medicine, 310009 Hangzhou, China and 3Institute of Bioengineering and Nanotechnology, 138669 Singapore
- Venue
- Nucleic Acids Research
- Publisher
- Oxford University Press (OUP)
- Published
- 2013-08-13
- Volume
- 41
- Issue
- 19
- Pages
- e180-e180
- ISSN
- 1362-4962
- 0305-1048
- PMC
- PMC3799456
- Cited by
- 52
- References
- 12
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.